APOE and atherosclerosis: In addition, treatment with the serine palmitoyltransferase inhibitor myriocin reversed endothelial dysfunction and atherosclerosis in streptozotocin-treated [29] and in apolipoprotein E (ApoE)-deficient mice [30].